Bladder Cancer and Urothelial Cancer Clinical Trials

Norton Cancer Institute is at the forefront of cancer treatment research. As principal investigators on numerous trials, our specialist physicians have access to innovative treatments and numerous bladder cancer clinical trials.

Learn more about participating in a clinical trial at Norton Healthcare.

Active bladder cancer and urothelial cancer clinical trials include:

Bladder Cancer

A Phase 3 Study of Erdafitinib Compared With Vinflunine or Docetaxel or Pembrolizumab in Subjects with Advanced Urothelial Cancer and Selected FGFR Gene Aberrations

Muscle Invasive Bladder Cancer (MIBC)

A Phase III, Randomized, Open-Label, Multi-Center, Global Study to Determine the Efficacy and Safety of Durvalumab in Combination with Gemcitabine+Cisplatin for Neoadjuvant Treatment Followed by Durvalumab Alone for Adjuvant Treatment in Patients with Muscle-Invasive Bladder […]

Urothelial Cancer

Retrospective Observational Study to Assess the Efficacy of Anti-PD-(L)1 Treatment in Subjects with Fibroblast Growth Factor Receptor Aberrations

Urothelial Cancer

A Phase 1b-2 Study to Evaluate Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Erdafitinib plus JNJ-63723283, an Anti-PD-1 Monoclonal Antibody, in Subjects with Metastatic or Surgically Unresectable Urothelial Cancer with Selected FGFR Gene Alterations

Urothelial Cancer

A Phase III, Randomized, Open Label, Controlled, Multi-Center, Global Study of First-Line Durvalumab in Combination with Standard of Care Chemotherapy and Durvalumab in Combination with Tremelimumab and Standard of Care Chemotherapy Versus Standard of Care […]

Urothelial Cancer

A Phase II Open Label, Study of IMMU-132 in Metastatic Urothelial Cancer after Failure of Platinum-Based Regimen or Anti-PD-1/ PD-L1 Based Immunotherapy

Urothelial Cancer

A single-arm, open-label, multicenter study of enfortumab vedotin (ASG-22CE) for treatment of patients with locally advanced or metastatic urothelial cancer who previously received immune checkpoint inhibitor (CPI) therapy

Urothelial Carcinoma

A PHASE III, MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND STUDY OF ATEZOLIZUMAB (ANTI?PD-L1 ANTIBODY) IN COMBINATION WITH GEMCITABINE/CARBOPLATIN VERSUS GEMCITABINE/CARBOPLATIN ALONE IN PATIENTS WITH UNTREATED LOCALLY ADVANCED OR METASTATIC UROTHELIAL CARCINOMA WHO ARE INELIGIBLE FOR CISPLATIN-BASED THERAPY

Urothelial Carcinoma

A Phase Ib/II Open Label, Multicenter, Randomized Umbrella Study Evaluating The Efficacy And Safety Of Multiple Immunotherapy-Based Treatment Combinations In Patients With Locally Advanced Or Metastatic Urothelial Carcinoma After Failure With Platinum-Containing Chemotherapy (MORPHEUS-mUC)

Urothelial Carcinoma

A Phase 2 Study of Sitravatinib in Combination with Nivolumab in Patients with Advanced or Metastatic Urothelial Carcinoma

Cancer – 4673

Appointments

Cancer care that isn’t too far from home.

(502) 629-HOPE (4673)


Request an Appointment Online

Clinical trials

Clinical Trials

Learn more about clinical trials at Norton Healthcare
(502) 629-3501

Nurses arrange Louisville Cardinals men’s basketball visit for cancer patient

Jeremiah Howe’s last wish was to go to Louisville Cardinals basketball game. With advanced cancer, he needed to remain in the hospital for care. But the nursing team at Norton Hospital started working their contacts […]

Read Full Story

Kentucky has country’s highest rate of lung cancer diagnoses; lung cancer screenings urged

Nearly one in every thousand Kentuckians will be newly diagnosed with lung cancer this year — the worst rate in the nation — and most of those cases will be found after the cancer has […]

Read Full Story

Study shows vaping nicotine could cause cancer

New research shows vaping’s dangers may extend beyond the recent wave of deaths from pulmonary disease, as vaping also may increase cancer risk. The first study linking vaping to cancer found nearly 25% of mice […]

Read Full Story

How to quit smoking: Make a plan

You’ve made the decision to quit smoking, now what? Don’t try to do it right away. You need to make a plan and let those closest to you know you have decided to quit. Accept […]

Read Full Story

Art therapist’s breast cancer journey fuels passion to help others with the disease

While Leigh Galloway undergoes her last chemotherapy treatment before a double mastectomy, she and Laura Chamberlin are engrossed in a watercolor. Like she does often with Laura, an expressive art therapist with Norton Cancer Institute […]

Read Full Story
Related Stories

Nurses arrange Louisville Cardinals men’s basketball visit for cancer patient

Jeremiah Howe’s last wish was to go to Louisville Cardinals basketball game. With advanced cancer, he needed to remain in the hospital for care. But the nursing team at Norton Hospital started working their contacts […]

Read Full Story

Kentucky has country’s highest rate of lung cancer diagnoses; lung cancer screenings urged

Nearly one in every thousand Kentuckians will be newly diagnosed with lung cancer this year — the worst rate in the nation — and most of those cases will be found after the cancer has […]

Read Full Story

Study shows vaping nicotine could cause cancer

New research shows vaping’s dangers may extend beyond the recent wave of deaths from pulmonary disease, as vaping also may increase cancer risk. The first study linking vaping to cancer found nearly 25% of mice […]

Read Full Story

How to quit smoking: Make a plan

You’ve made the decision to quit smoking, now what? Don’t try to do it right away. You need to make a plan and let those closest to you know you have decided to quit. Accept […]

Read Full Story

Art therapist’s breast cancer journey fuels passion to help others with the disease

While Leigh Galloway undergoes her last chemotherapy treatment before a double mastectomy, she and Laura Chamberlin are engrossed in a watercolor. Like she does often with Laura, an expressive art therapist with Norton Cancer Institute […]

Read Full Story

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.